O=C(Nc1ccc2c(c1)OCO2)c1c[nH]c(=O)n(-c2ccc(F)cc2)c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?